Literature DB >> 7612550

Ocular blood flow velocities in patients with proliferative diabetic retinopathy and healthy volunteers: a prospective study.

A Mendívil1, V Cuartero, M P Mendívil.   

Abstract

BACKGROUND: Diabetes affects the vascular ocular circulation. Colour Doppler imaging allows for simultaneous two dimensional anatomical imaging and Doppler evaluation of blood flow velocity; with this technique ocular blood flow velocity can be evaluated in normal and diabetic patients.
METHODS: A prospective study compared blood flow velocity in ocular vessels (ophthalmic artery, posterior ciliary arteries, central retinal vessels, and vortex veins) of 25 patients with proliferative diabetic retinopathy and 30 age matched normal subjects using a colour Doppler imaging unit (Toshiba Sonolayer SSA-270 A with a 5.0 MHz PLF-503 ST phased array scanning head).
RESULTS: The diabetic patients had lower blood velocities than the volunteers. There were significant differences in ophthalmic artery; systolic (p < 0.01), diastolic (p < 0.001), mean velocity (p < 0.05), and central retinal artery; systolic (p < 0.001), diastolic (p < 0.001), mean velocity (p < 0.05). No significant correlations were found between age and blood velocities.
CONCLUSION: Ocular blood flow velocity was decreased in diabetic patients with proliferative diabetic retinopathy.

Entities:  

Mesh:

Year:  1995        PMID: 7612550      PMCID: PMC505126          DOI: 10.1136/bjo.79.5.413

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  32 in total

1.  Color Doppler imaging of the eye and orbit. Technique and normal vascular anatomy.

Authors:  W E Lieb; S M Cohen; D A Merton; J A Shields; D G Mitchell; B B Goldberg
Journal:  Arch Ophthalmol       Date:  1991-04

2.  Doppler ultrasonography of the ophthalmic and central retinal vessels.

Authors:  R F Guthoff; R W Berger; P Winkler; K Helmke; L C Chumbley
Journal:  Arch Ophthalmol       Date:  1991-04

Review 3.  Clinical Doppler imaging.

Authors:  E G Grant; F N Tessler; R R Perrella
Journal:  AJR Am J Roentgenol       Date:  1989-04       Impact factor: 3.959

4.  Blood velocity and volumetric flow rate in human retinal vessels.

Authors:  C E Riva; J E Grunwald; S H Sinclair; B L Petrig
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-08       Impact factor: 4.799

5.  Platelet aggregation in type I diabetics with and without proliferative retinopathy.

Authors:  C D Agardh; E Agardh; B Bauer
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-06

6.  Retinal blood flow in diabetic retinopathy.

Authors:  V Patel; S Rassam; R Newsom; J Wiek; E Kohner
Journal:  BMJ       Date:  1992-09-19

7.  Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network.

Authors:  O Arend; S Wolf; F Jung; B Bertram; H Pöstgens; H Toonen; M Reim
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

8.  Macular blood flow response to acute reduction of plasma glucose in diabetic patients measured by the blue light entoptic technique.

Authors:  E G Davies; S L Hyer; E M Kohner
Journal:  Ophthalmology       Date:  1990-02       Impact factor: 12.079

9.  Aggregate formation of erythrocytes and diabetic retinopathy in children, adolescents, and adults with diabetes mellitus (type I).

Authors:  W Tillmann; M Lakomek; P Heidemann; W Behrens-Baumann; W Schröter
Journal:  Klin Wochenschr       Date:  1984-12-03

10.  Hypoxic viscosity and diabetic retinopathy.

Authors:  T Rimmer; J Fleming; E M Kohner
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

View more
  18 in total

1.  Twelve hour reproducibility of choroidal blood flow parameters in healthy subjects.

Authors:  E Polska; K Polak; A Luksch; G Fuchsjager-Mayrl; V Petternel; O Findl; L Schmetterer
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy.

Authors:  A Ozkiris; K Erkiliç; A Koç; S Mistik
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

3.  Non-invasive vascular impedance measures demonstrate ocular vasoconstriction during isometric exercise.

Authors:  Andrew J Morgan; Sarah L Hosking
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

4.  Correlation between higher blood flow velocity in the central retinal vein than in the central retinal artery and severity of nonproliferative diabetic retinopathy.

Authors:  Sayuri Fujioka; Kaoruko Karashima; Norikiyo Nishikawa; Yoshihiro Saito
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

5.  Improved Macular Capillary Flow on Optical Coherence Tomography Angiography After Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.

Authors:  Amani A Fawzi; Alaa E Fayed; Robert A Linsenmeier; Jing Gao; Fei Yu
Journal:  Am J Ophthalmol       Date:  2019-05-10       Impact factor: 5.258

6.  Ocular circulation in diabetic patients with coronary artery disease.

Authors:  Sayuri Fujioka; Kaoruko Karashima; Norikiyo Nishikawa; Yoshihiro Saito
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02       Impact factor: 3.117

7.  Orbital color Doppler imaging of optic nerve tumors.

Authors:  C Jacquemin; T Bosley; P Mullaney
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

8.  Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation.

Authors:  M N Alp; A Ozgen; I Can; P Cakar; I Gunalp
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

9.  Orbital Doppler evaluation of blood flow velocities in patients with diabetic retinopathy.

Authors:  Mehdi Karami; Mohsen Janghorbani; Alireza Dehghani; Karim Khaksar; Ahmad Kaviani
Journal:  Rev Diabet Stud       Date:  2012-11-15

10.  Retinal blood flow detection in diabetic patients by Doppler Fourier domain optical coherence tomography.

Authors:  Yimin Wang; Amani Fawzi; Ou Tan; John Gil-Flamer; David Huang
Journal:  Opt Express       Date:  2009-03-02       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.